Stevanato Group S.p.A. (STVN) Fair Value 2026

STVN · Medical Instruments & Supplies ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

7.7 /10

32 fundamental signals · 10 models active

Value Trap Risk

SAFE (24/100)

Quick Summary — As of 2026-08-28, Stevanato Group S.p.A. (STVN) trades at $21.03, versus a $7.89 median fair value across its 10 active models — 62.5% below the current price. QOC: 7.7/10. Value Trap Risk: 24/100 (SAFE). 10/13 models active.

Key Facts

Ticker
STVN
Price
$21.03
Quality Score
7.7/10
Value Trap Risk
24/100
Models Active
10/13
Last Updated
Strength: First Chicago suggests +6.7% upside with 55% confidence
Risk: Majority of models suggest overvaluation

Is Stevanato Group S.p.A. (STVN) Undervalued or Overvalued in 2026?

According to CirclFi’s 10-model valuation engine, Stevanato Group S.p.A. (STVN) appears overvalued as of : the median of 10 independent fair value estimates is $7.89, 62.5% below the current price of $21.03. Estimates range from $0.21 to $29.74. STVN scores 7.7/10 on fundamental quality and 24/100 on value-trap risk.

For context, the median US equity CirclFi rates trades at an implied -23.4% versus its own 13-model consensus, across 3,809 rated companies as of 2026-08-28. STVN’s -62.5% gap is wider than that market norm, and the Medical Instruments & Supplies sector median is -29.3%. Full market index →

This verdict compares price to intrinsic value only — it is not a buy or sell rating. For the decision case (bull vs bear arguments, risk factors, peers), read Should You Buy Stevanato Group S.p.A. Stock in 2026? →

What Fair Value Does Each Model Give STVN?

10 Intrinsic Value Models vs. Current Price ($21.03)

Core Models (Unlocked)
Model Fair Value Upside
Intrinsic · High Conviction
 $5.94 -71.7%
Ensemble · Low Conviction
 $8.98 -57.3%
Scenario · High Conviction
 $22.45 +6.7%
Intrinsic · High Conviction
 $6.41 -69.5%
Unlock the Full Matrix

Access 6 additional models including Markov DDM, ML-RIV, and more.

$1.30 / day

Billed monthly ($39/mo) or annually ($299/yr)

Unlock All 10 Models →

Cancel anytime · No contracts · Instant access

What Is STVN's Fair Value Range?

Spread across 10 independent models · $0.21 to $29.74

CirclFi's 10 active models place Stevanato Group S.p.A. (STVN) between $0.21 and $29.74 per share, a spread of 374% of the median. The median of that range — $7.89 — is the fair value CirclFi publishes for STVN, against a current price of $21.03.

Low · RCMH-DCFHigh · Regime Cross
$0.21median $7.89$29.74
Where the range comes from
Most bearish modelRCMH-DCF$0.21
Most bullish modelRegime Cross-Sectional$29.74
Model agreement2 bullish · 8 bearishwide

A band this wide is itself the finding. When independent methods land far apart, they are reading a business whose value depends heavily on which lens you apply — volatile earnings, heavy reinvestment, or an asset base that cash-flow and asset-based methods score differently. That disagreement is information: it says the choice of method matters more than usual for STVN. Treat the median as one reading among several and compare the individual models below before acting.

Every figure above is one model's standalone output on STVN, not a CirclFi price target. How each model works →

What Is Stevanato Group S.p.A. (STVN) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, Stevanato Group S.p.A.'s intrinsic value is estimated at $7.89, suggesting the stock is overvalued at its current price of $21.03. With 8 out of 10 models flagging downside (-62.5% vs price), the market may be pricing in unsustainable growth. Notably, Regime Cross sees the most upside at +41.4% (fair value: $29.74), while RCMH-DCF is the most conservative at -99.0% ($0.21). The spread between these extremes — +140.4% — reveals how different analytical frameworks can reach starkly different conclusions. Among models with highest confidence, EPV lean bearish — adding weight to the bearish side of the thesis.

What Do the Models Say About STVN?

10 of 13 models are currently active for STVN. Of these, 2 models suggest upside while 8 models suggest overvaluation. Taken together, their median fair value for STVN is $7.89 — the figure CirclFi publishes as this stock's fair value. See which stocks rank higher →

How Does STVN Rank in Medical Instruments & Supplies?

Among 56 Medical Instruments & Supplies stocks, STVN ranks #17 by Quality of Company score. CirclFi's QOC score of 7.7/10 evaluates 32 fundamental signals. A score of 7.7 indicates above-average quality.

See all Most Undervalued Medical Instruments & Supplies Stocks →

Stevanato Group S.p.A. operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.

Is STVN a Value Trap?

CirclFi's Value Trap algorithm assigns STVN a score of 24/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

10 of 13 models are active for Stevanato Group S.p.A.. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Quality of Company (QOC) framework, which evaluates 32 signals including margin stability, revenue growth trajectory, leverage, and free cash flow generation, Stevanato Group S.p.A. is rated at 7.7/10. This strong-tier score demonstrates strong fundamentals across the majority of our quality signals.

The gap between the most bullish and bearish model spans +140.4% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every STVN valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across STVN's 10 active models, average confidence is 41%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Stevanato Group S.p.A. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Medical Instruments & Supplies Stocks Should You Also Analyze?

11 related Medical Instruments & Supplies stocks with 13-model coverage

ATRCAtriCure, Inc.QOC 7.8MDLNMedline Inc.QOC 7.7PDEXPro-Dex, Inc.QOC 7.8WRBYWarby Parker Inc.QOC 7.6EMBCEmbecta Corp.QOC 7.8ICUIICU Medical, Inc.QOC 7.5BAXBaxter International Inc.QOC 6.3LUCYLucyd, IncQOC 5.6LMATLeMaitre Vascular, Inc.QOC 9.3ISRGIntuitive Surgical, Inc.QOC 9.4RMDResMed Inc.QOC 9.4

Read investment analysis: ATRC · MDLN · PDEX · WRBY · EMBC · ICUI · BAX · LUCY · LMAT · ISRG · RMD

Which Other Stocks Have a Similar Quality Score to STVN?

7 companies across all industries closest to STVN’s Quality of Company score of 7.7/10.

MNRMach Natural Resources LPQOC 7.7AATAmerican Assets Trust, Inc.QOC 7.7SRSpire Inc.QOC 7.7SGCSuperior Group of Companies, Inc.QOC 7.7TTWOTake-Two Interactive Software, Inc.QOC 7.7WAYWaystar Holding Corp.QOC 7.7NVDANVIDIA CorporationQOC 10.0

Read investment analysis: MNR · AAT · SR · SGC · TTWO · WAY · NVDA

Where Does STVN Sit in CirclFi's Medical Instruments & Supplies Rankings?

STVN is ranked against every other Medical Instruments & Supplies stock CirclFi covers in each of these screens.

See all Medical Instruments & Supplies stocks ranked →

What Else Do Investors Ask About Stevanato Group S.p.A.’s Valuation?

What is Stevanato Group S.p.A.'s intrinsic value in 2026?

CirclFi puts Stevanato Group S.p.A. (STVN)'s intrinsic value at $7.89 — the median of 10 independent model estimates as of 2026-08-28, ranging from $0.21 to $29.74. The Quality of Company score is 7.7/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is STVN overvalued or undervalued right now?

At $21.03, 2 of 10 active models suggest STVN may be undervalued, while 8 indicate potential overvaluation. The median of all 10 fair value estimates is $7.89, 62.5% below the current price of $21.03 — a consensus view that STVN is overvalued. The assessment depends on which methodology best fits Stevanato Group S.p.A.'s business model in Medical Instruments & Supplies.

What does a Quality of Company score of 7.7 mean for STVN?

Stevanato Group S.p.A.'s QOC of 7.7/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores above 7 indicate strong fundamentals and disciplined management.

How many valuation models does CirclFi run on STVN?

CirclFi analyzes STVN with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 10 of 13 are active for this stock. Read the full methodology →

Which valuation models are most bullish and most bearish on STVN?

Of the 10 models currently active on STVN, Regime Cross-Sectional is the most bullish at $29.74 per share, and RCMH-DCF is the most bearish at $0.21. CirclFi's published fair value for STVN is the median of that range, $7.89, not either extreme. The gap between the two ends equals 374% of the median — a wide spread, meaning the methods genuinely disagree and the median should carry less weight. Browse stocks by value-trap risk →

Is STVN a value trap in 2026?

Stevanato Group S.p.A.'s Value Trap score is 24/100 (SAFE). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap.

Cite this analysis — “According to CirclFi’s 10-model valuation engine, Stevanato Group S.p.A. (STVN) has a median fair value of $7.89 — 62.5% below the current price of $21.03 — as of 2026-08-28.” Source: circlfi.com/stock/STVN/ · Methodology
Primary sources for this STVN valuation
  • Financial statements: Stevanato Group S.p.A. 10-K and 10-Q filings on SEC EDGAR (CIK 0001849853) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for STVN as of ; valuations recomputed .

You’ve done the research. Don’t stop at half the picture.

Stop collecting opinions. Let 10 mathematical frameworks give you clarity on STVN.

Unlock All 10 Fair Values — $39/mo

Cancel anytime · Less than a cup of coffee · Instant access

6 models hidden for STVN Unlock All 10 — $39/mo